Two publications from the past week:
- Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States | link
- Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.
3 thoughts on “New publications in health economics and genomics 3rd November 2020”
Just noticed one that might be relevant:
Peters Y, Siersema PD. Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment. Clinical and Translational Gastroenterology. 2020 Nov;11(11).
Thanks – I’m not sure I can see the genomics angle in that paper, but perhaps I’m missing something?
Sorry James, my mistake I’ll read more carefully next if I post again